Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

HALEOS LABS LTD.

NSE : HALEOSLABSBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE1355.7541.95 (+3.19 %)

PREV CLOSE ( ) 1313.80

OPEN PRICE ( ) 1360.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4

TODAY'S LOW / HIGH ( )1355.75 1360.00

52 WK LOW / HIGH ( )956.05 1680

NSE1300.0018.1 (+1.41 %)

PREV CLOSE( ) 1281.90

OPEN PRICE ( ) 1280.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1300.00 (10)

VOLUME 357

TODAY'S LOW / HIGH( ) 1231.00 1300.00

52 WK LOW / HIGH ( )959.8 1680

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-05 2006

Management Info

- Chairman TVVSN Murthy - Managing Director

Registered Office

Address Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone 040-66288888

Email info@smslife.in

Website www.smslife.in

Registrars Details

Aarthi Consultants Pvt Ltd

1-2-285 ,Domalaguda,,Hyderabad

Listing : BSE, NSE

NEWS

21Jan Haleos Labs enters into strategic Deve
Haleos Labs has entered into strategic Development collaboration with HR..

21Jan Haleos Labs informs about collaboratio
Haleos Labs has informed that the Company has entered into strategic Dev..

10Nov SMS Lifesciences India informs about o
SMS Lifesciences India has informed that the Board of Directors of the C..

14Oct Haleos Labs informs about certificate
Haleos Labs has informed that it enclosed the Certificate received from..

20Sep SMS Lifesciences India informs about c
SMS Lifesciences India has informed that Trading Window for dealing in s..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	54.06	213.7
Gross Profit	74.87	300.4
Operating Profit	116.38	481.77
Net Sales	807.19	3333.71

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 13043.80 (0.65%)	M.Cap ( in Cr)16735.05
Kwality Pharma (BSE) 1431.20 (5.08%)	M.Cap ( in Cr)1485.04
Sanofi Cons. Health (BSE) 4299.65 (1.54%)	M.Cap ( in Cr)9902.36
Astrazeneca Pharma I (BSE) 8878.75 (0.59%)	M.Cap ( in Cr)22196.88
NGL Fine-Chem (BSE) 2291.65 (2.29%)	M.Cap ( in Cr)1415.79

Shareholding Pattern

	PROMOTERS	71.8%
	NON-INSTITUTION	27.91%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

HALEOS LABS LTD.